ferric nitrilotriacetate has been researched along with Skin Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, Y; Chau, TT; Kitajima, S; Miyata, Y; Ohgari, Y; Taketani, S | 1 |
| Andrei, G; Boelaert, JR; Dieye, T; Farber, CM; Heenen, M; Hermans, P; Lambert, C; Liesnard, C; Lunardi-Yskandar, Y; Noel, JC; Parent, D; Simonart, T; Snoeck, R; Van Vooren, JP | 1 |
| Oberley, TD | 1 |
3 other study(ies) available for ferric nitrilotriacetate and Skin Neoplasms
| Article | Year |
|---|---|
Quinolone compounds enhance delta-aminolevulinic acid-induced accumulation of protoporphyrin IX and photosensitivity of tumour cells.
Topics: Aminolevulinic Acid; Drug Synergism; Female; Ferric Compounds; Fluoroquinolones; HeLa Cells; Heme Oxygenase (Decyclizing); Hemin; Humans; Iron; Light; Metalloporphyrins; Nitrilotriacetic Acid; Oxidation-Reduction; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Reactive Oxygen Species; Skin Neoplasms | 2011 |
Iron as a potential co-factor in the pathogenesis of Kaposi's sarcoma?
Topics: Carcinogens; Cell Division; Chelating Agents; Chlorides; Deferoxamine; Ferric Compounds; Fibroblast Growth Factor 2; Humans; Iron; Nitrilotriacetic Acid; Sarcoma, Kaposi; Skin Neoplasms; Tumor Cells, Cultured | 1998 |
Oxidative damage and cancer.
Topics: Animals; Antioxidants; Carcinogens; Disease Models, Animal; Ferric Compounds; Free Radical Scavengers; Gene Silencing; Humans; Kidney Neoplasms; Neoplasms; Nitrilotriacetic Acid; Oxidation-Reduction; Reactive Oxygen Species; Skin Neoplasms; Superoxide Dismutase | 2002 |